Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Opioids
Gottlieb Discusses Opioids and Lays Out Vision – Google it’s…
On Wednesday, April 4, 2018, Food and Drug Administration (FDA) Commissioner Scott Gottlieb spoke at the National Rx Drug Abuse…
House of Representatives Holds Two-Day Hearing on Opioids
Recently the Committee on Energy and Commerce Subcommittee on Health held a hearing entitled, “Combating the Opioid Crisis:…
NQF Issues Guidance on Opioid Prescribing Practices
The National Qualify Forum (NQF) recently released new guidelines to support safe and appropriate opioid prescribing to…
Teva and McCaskill: A Game of Cat and Mouse
In Summer 2017, we wrote about Senator Claire McCaskill’s request to Teva Pharmaceutical Industries that they provide…
CARA 2.0 Introduced by Bipartisan Group of Senators
A bipartisan group of senators have introduced legislation framed as a follow-up bill to the Comprehensive Addiction and Recovery…
White House White Paper on Pharma Pricing Released
In February 2018, the White House Council of Economic Advisers released a white paper, “Reforming Biopharmaceutical Pricing at…
E&C House Subcommittee Slated to Review Eight Bills on Opioids
Recently, the House Energy & Commerce Health Subcommittee announced that it will hold a hearing on Wednesday, February 28,…
Senate HELP Committee Holds Hearing on Opioids and the Impact on Families
On February 8, 2018, the Senate Health, Education, Labor, and Pensions (HELP) committee held a hearing entitled “Impact of the…
House Holds Hearing on Opioid Crisis
On January 17, 2018, the House Ways and Means Subcommittee on Oversight held a hearing entitled “The Opioid Crisis: The Current…
FDA REMS Blueprint on Opioids Finalized
On January 30, 2018, the United States Food and Drug Administration (FDA) finalized the “Opioid Analgesic REMS Education…